$1.04 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 121 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ABEO | Exit | ABEONA THERAPEUTICS INC | $0 | – | -186,350 | -100.0% | -0.05% | – |
CBAY | Exit | CYMABAY THERAPEUTICS INCcall | $0 | – | -354,000 | -100.0% | -0.06% | – |
PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -64,000 | -100.0% | -0.06% | – |
EOLS | Exit | EVOLUS INC | $0 | – | -141,442 | -100.0% | -0.07% | – |
AXSM | Exit | AXSOME THERAPEUTICS INCcall | $0 | – | -10,000 | -100.0% | -0.07% | – |
CRBP | Exit | CORBUS PHARMACEUTICALS HLDGS | $0 | – | -120,000 | -100.0% | -0.08% | – |
HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -32,816 | -100.0% | -0.12% | – |
ZBH | Exit | ZIMMER BIOMET HOLDINGS INCcall | $0 | – | -10,000 | -100.0% | -0.12% | – |
NLTX | Exit | NEOLEUKIN THERAPEUTICS INC | $0 | – | -97,397 | -100.0% | -0.13% | – |
AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -98,913 | -100.0% | -0.17% | – |
SELB | Exit | SELECTA BIOSCIENCES INC | $0 | – | -624,755 | -100.0% | -0.18% | – |
NVRO | Exit | NEVRO CORP | $0 | – | -20,000 | -100.0% | -0.24% | – |
AMRN | Exit | AMARIN CORP PLCput | $0 | – | -517,600 | -100.0% | -0.25% | – |
IMMU | Exit | IMMUNOMEDICS INCput | $0 | – | -165,600 | -100.0% | -0.26% | – |
IMVTU | Exit | IMMUNOVANT INCunit 12/18/2024 | $0 | – | -175,010 | -100.0% | -0.34% | – |
CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -110,899 | -100.0% | -0.39% | – |
PPD | Exit | PPD INC | $0 | – | -205,000 | -100.0% | -0.43% | – |
GILD | Exit | GILEAD SCIENCES INC | $0 | – | -50,000 | -100.0% | -0.44% | – |
KALA | Exit | KALA PHARMACEUTICALS INCput | $0 | – | -436,700 | -100.0% | -0.46% | – |
GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -55,000 | -100.0% | -0.49% | – |
QDEL | Exit | QUIDEL CORP | $0 | – | -51,999 | -100.0% | -0.60% | – |
VAR | Exit | VARIAN MED SYS INCput | $0 | – | -52,500 | -100.0% | -0.64% | – |
REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -11,212 | -100.0% | -0.65% | – |
MTUM | Exit | ISHARES TRput | $0 | – | -60,000 | -100.0% | -0.76% | – |
TMO | Exit | THERMO FISHER SCIENTIFIC INCput | $0 | – | -27,500 | -100.0% | -0.93% | – |
QQQ | Exit | INVESCO QQQ TRput | $0 | – | -67,500 | -100.0% | -1.53% | – |
ATRC | Exit | ATRICURE INCcall | $0 | – | -565,000 | -100.0% | -2.25% | – |
LLY | Exit | LILLY ELI & COput | $0 | – | -150,000 | -100.0% | -2.47% | – |
MDT | Exit | MEDTRONIC PLCcall | $0 | – | -475,000 | -100.0% | -5.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ICU MED INC | 26 | Q2 2023 | 4.2% |
NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
VIEWRAY INC | 25 | Q2 2023 | 3.2% |
LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
INVACARE CORP | 22 | Q3 2021 | 2.8% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2024-02-13 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.